Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets

por Vann, Kendra R., Pal, Dhananjaya, Morales, Guillermo A., Burgoyne, Adam M., Durden, Donald L., Kutateladze, Tatiana G.
Publicado 2020

Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers

por Okamura, Ryosuke, Kurzrock, Razelle, Mallory, Robert J., Fanta, Paul T., Burgoyne, Adam M., Clary, Bryan M., Kato, Shumei, Sicklick, Jason K.
Publicado 2020

Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma

por Banerjee, Sudeep, Corless, Christopher L., Miettinen, Markku M., Noh, Sangkyu, Ustoy, Rowan, Davis, Jessica L., Tang, Chih-Min, Yebra, Mayra, Burgoyne, Adam M., Sicklick, Jason K.
Publicado 2019

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity

por Burgoyne, Adam M., Vann, Kendra R., Joshi, Shweta, Morales, Guillermo A., Vega, Francisco M., Singh, Alok, Pal, Dhananjaya, Merati, Aran B., Kutateladze, Tatiana G., Durden, Donald L.
Publicado 2020

Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy

por Dehghan, Yalda, Schnickel, Gabriel T., Hosseini, Mojgan, Burgoyne, Adam M., Ajmera, Veeral H., Morris, Gerald P., Mendler, Michel H., Parekh, Justin R., Abushamat, Farid, Vodkin, Irine, Kono, Yuko
Publicado 2021

Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma

por Franses, Joseph W, Lim, Mir, Burgoyne, Adam M, Mody, Kabir, Lennerz, Jochen, Chang, Jeremy, Imperial, Robin, Dybel, Stacey N, Dinh, Thi M, Masannat, Jude, Weipert, Caroline M, Hsiehchen, David
Publicado 2022

Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression

por Tang, Chih-Min, Lee, Tracy E., Syed, Sabriya A., Burgoyne, Adam M., Leonard, Stephanie Y., Gao, Fei, Chan, Jonathan C., Shi, Eileen, Chmielecki, Juliann, Morosini, Deborah, Wang, Kai, Ross, Jeffrey S., Kendrick, Michael L., Bardsley, Michael R., De Siena, Martina, Mao, Junhao, Harismendy, Olivier, Ordog, Tamas, Sicklick, Jason K.
Publicado 2016

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

por Shi, Eileen, Chmielecki, Juliann, Tang, Chih-Min, Wang, Kai, Heinrich, Michael C., Kang, Guhyun, Corless, Christopher L., Hong, David, Fero, Katherine E., Murphy, James D., Fanta, Paul T., Ali, Siraj M., De Siena, Martina, Burgoyne, Adam M., Movva, Sujana, Madlensky, Lisa, Heestand, Gregory M., Trent, Jonathan C., Kurzrock, Razelle, Morosini, Deborah, Ross, Jeffrey S., Harismendy, Olivier, Sicklick, Jason K.
Publicado 2016

Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis

por Yoon, Hyunho, Tang, Chih-Min, Banerjee, Sudeep, Yebra, Mayra, Noh, Sangkyu, Burgoyne, Adam M., Torre, Jorge De la, Siena, Martina De, Liu, Mengyuan, Klug, Lillian R., Choi, Yoon Young, Hosseini, Mojgan, Delgado, Antonio L., Wang, Zhiyong, French, Randall P., Lowy, Andrew, DeMatteo, Ronald P., Heinrich, Michael C., Molinolo, Alfredo A., Gutkind, J. Silvio, Harismendy, Olivier, Sicklick, Jason K.
Publicado 2021